论文部分内容阅读
消痔灵是针对痔疮最近推出的一种新的注射用硬化剂,我们近年来将这种药物应用于体表血管瘤注射,取得较满意的效果,现报道如下:一、一般资料本组36例中,共有瘤体42个.单纯毛细血管瘤11例;毛细血管瘤16例;混合型血管瘤2例。19例出生时就有。单生在颜面部19例,四肢9例,躯干4例,面部与四肢同时存在4例,躯干四肢同时存在2例。年龄15岁以下34例,15岁以上2例,病史最长15年、最短两个月。二、治疗方法1.药液准备:5cc 注射器,取消痔灵原液与普鲁卡因配制为1.5:1溶液,接上6至7号针头备用。2.药物选择:北京第四制药厂研制消痔
Xiaozhiling is a new injection of hardener for hemorrhoids recently introduced, we in recent years this drug is applied to the injection of body surface hemangioma and achieved more satisfactory results are reported as follows: First, the general information of the group 36 In our study, there were 42 aneurysms, 11 simple capillary hemangiomas, 16 capillary hemangiomas and 2 mixed hemangiomas. 19 cases were born. In the facial area, 19 cases were single, 9 cases were limbs, 4 cases were trunk, 4 cases were facial and limbs simultaneously, and 2 cases were trunk and limbs simultaneously. 34 cases under the age of 15, 2 cases over the age of 15, the longest history of 15 years, the shortest two months. Second, the treatment 1 liquid preparation: 5cc syringe, cancel the hemorrhoids solution and procaine prepared as a 1.5: 1 solution, connected to 6 to 7 needles spare. 2. Drug Choice: Beijing No.4 Pharmaceutical Factory developed hemorrhoid